Reliability and validity of the Korean version of the University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis
Tae Hee Lee, Joon Seong Lee, Suyeon Park, Kyung-Ann Lee, Hyun-Sook Kim
Korean J Intern Med. 2021;36(6):1504-1514. Published online 2021 Feb 10 DOI: https://doi.org/10.3904/kjim.2020.190
Citations to this article as recorded by 
Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study
Laura Cano-García, Rocío Redondo-Rodríguez, Natalia Mena-Vázquez, Sara Manrique-Arija, Aimara García-Studer, Fernando Ortiz-Marquez, Paula Borregón-Garrido, Antonio Fernández-Nebro
BMJ Open.2024; 14(4): e083419. CrossRef
Development and validation of Hebrew version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0
David Ozeri, Shani Peretz, Amit Oppenheim, Abdallah Watad, Merav Lidar, Yolanda Braun-Moscovici
Journal of Scleroderma and Related Disorders.2023; 8(1): 31. CrossRef